These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30987721)

  • 21. p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.
    Wu IW; Hsu KH; Lee CC; Sun CY; Hsu HJ; Tsai CJ; Tzen CY; Wang YC; Lin CY; Wu MS
    Nephrol Dial Transplant; 2011 Mar; 26(3):938-47. PubMed ID: 20884620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.
    Meijers BK; De Loor H; Bammens B; Verbeke K; Vanrenterghem Y; Evenepoel P
    Clin J Am Soc Nephrol; 2009 Dec; 4(12):1932-8. PubMed ID: 19833905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Liver in Determining Serum Colon-Derived Uremic Solutes.
    Lin CJ; Liou TC; Pan CF; Wu PC; Sun FJ; Liu HL; Chen HH; Wu CJ
    PLoS One; 2015; 10(8):e0134590. PubMed ID: 26258409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Levels of Total p-Cresylsulfate Are Associated with Pruritus in Patients with Chronic Kidney Disease.
    Wang CP; Lu YC; Tsai IT; Tang WH; Hsu CC; Hung WC; Yu TH; Chen SC; Chung FM; Lee YJ; Houng JY
    Dermatology; 2016; 232(3):363-70. PubMed ID: 27161100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography.
    de Loor H; Meijers BK; Meyer TW; Bammens B; Verbeke K; Dehaen W; Evenepoel P
    J Chromatogr A; 2009 May; 1216(22):4684-8. PubMed ID: 19394619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.
    Deltombe O; Van Biesen W; Glorieux G; Massy Z; Dhondt A; Eloot S
    Toxins (Basel); 2015 Sep; 7(10):3933-46. PubMed ID: 26426048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up.
    Lin CJ; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
    Arch Med Res; 2013 Oct; 44(7):535-41. PubMed ID: 24055267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease.
    Yeh YC; Huang MF; Liang SS; Hwang SJ; Tsai JC; Liu TL; Wu PH; Yang YH; Kuo KC; Kuo MC; Chen CS
    Neurotoxicology; 2016 Mar; 53():148-152. PubMed ID: 26797588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of sucroferric oxyhydroxide on gastrointestinal microbiome and uremic toxins in patients with chronic kidney disease undergoing hemodialysis.
    Iguchi A; Yamamoto S; Oda A; Tanaka K; Kazama JJ; Saeki T; Yamazaki H; Ishioka K; Suzutani T; Narita I
    Clin Exp Nephrol; 2020 Aug; 24(8):725-733. PubMed ID: 32285213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.
    Vanholder R; Schepers E; Pletinck A; Nagler EV; Glorieux G
    J Am Soc Nephrol; 2014 Sep; 25(9):1897-907. PubMed ID: 24812165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-Cresol Sulfate in Hemodialysis Patients: Results From an In Vitro Study and An In Vivo Pilot Trial (xuanro4-Nature 3.2).
    Rocchetti MT; Cosola C; di Bari I; Magnani S; Galleggiante V; Scandiffio L; Dalfino G; Netti GS; Atti M; Corciulo R; Gesualdo L
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32164382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indoxyl sulfate, not P-cresyl sulfate, is associated with advanced glycation end products in patients on long-term hemodialysis.
    Lin CJ; Lin J; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
    Kidney Blood Press Res; 2015; 40(2):121-9. PubMed ID: 25833743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
    Sato E; Saigusa D; Mishima E; Uchida T; Miura D; Morikawa-Ichinose T; Kisu K; Sekimoto A; Saito R; Oe Y; Matsumoto Y; Tomioka Y; Mori T; Takahashi N; Sato H; Abe T; Niwa T; Ito S
    Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29283413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does Low-Protein Diet Influence the Uremic Toxin Serum Levels From the Gut Microbiota in Nondialysis Chronic Kidney Disease Patients?
    Black AP; Anjos JS; Cardozo L; Carmo FL; Dolenga CJ; Nakao LS; de Carvalho Ferreira D; Rosado A; Carraro Eduardo JC; Mafra D
    J Ren Nutr; 2018 May; 28(3):208-214. PubMed ID: 29439931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
    Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis.
    Chen X; Gao S; Ruan M; Chen S; Xu J; Xing X; Pan X; Mei C; Mao Z
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29921575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indoxyl sulfate and p-cresyl sulfate in chronic kidney disease. Could these toxins modulate the antioxidant Nrf2-Keap1 pathway?
    Stockler-Pinto MB; Fouque D; Soulage CO; Croze M; Mafra D
    J Ren Nutr; 2014 Sep; 24(5):286-91. PubMed ID: 24480117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between Protein-Bound Uremic Toxins and Asymptomatic Cardiac Dysfunction in Patients with Chronic Kidney Disease.
    Chinnappa S; Tu YK; Yeh YC; Glorieux G; Vanholder R; Mooney A
    Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30563136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism, Protein Binding, and Renal Clearance of Microbiota-Derived p-Cresol in Patients with CKD.
    Poesen R; Evenepoel P; de Loor H; Kuypers D; Augustijns P; Meijers B
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1136-1144. PubMed ID: 27084876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.
    Wang CH; Cheng ML; Liu MH; Shiao MS; Hsu KH; Huang YY; Lin CC; Lin JF
    Heart Vessels; 2016 Jul; 31(7):1100-8. PubMed ID: 26135926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.